Involvement of cAMP-dependent protein kinase and protein phosphorylation in regulation of mouse oocyte maturation

Developmental Biology
|April 1, 1986
PubMed

Insights

A decrease in cyclic AMP (cAMP) in mouse oocytes triggers meiotic maturation. Inhibiting cAMP or its signaling pathway with phosphodiesterase (PDE) or protein kinase (PK) inhibitors initiates maturation, while activating PK maintains arrest.

Area of Science:

  • Cell Biology
  • Developmental Biology
  • Reproductive Biology

Background:

  • Meiotic maturation in oocytes is a critical process for reproduction.
  • Cyclic AMP (cAMP) is known to play a role in maintaining meiotic arrest in oocytes.
  • The precise mechanisms by which cAMP regulates this process are still being investigated.

Purpose of the Study:

  • To investigate the role of intracellular cyclic AMP (cAMP) levels in initiating meiotic maturation in mouse oocytes.
  • To elucidate the involvement of cAMP-dependent protein kinase (PK) in mediating meiotic arrest.

Main Methods:

  • Microinjection of mouse oocytes with cyclic nucleotide phosphodiesterase (PDE), 2'-deoxy cAMP, cAMP, protein kinase (PK) inhibitors (PKI), and PK catalytic subunits.
  • Inhibition and activation of signaling pathways using specific chemical agents like 3-isobutyl-1-methylxanthine (IBMX) and dibutyryl cAMP (dbcAMP).
  • Analysis of germinal vesicle breakdown (GVBD) as an indicator of meiotic maturation and examination of oocyte phosphoprotein changes.

Main Results:

  • Microinjection of PDE induced germinal vesicle breakdown (GVBD), indicating meiotic maturation, even in the presence of IBMX.
  • 2'-deoxy cAMP failed to maintain meiotic arrest, unlike cAMP, suggesting cAMP's role in PK activation.
  • Microinjection of PK inhibitor (PKI) induced GVBD, while PK catalytic subunit maintained meiotic arrest, demonstrating the involvement of PK in regulating maturation.

Conclusions:

  • A decrease in intraoocyte cAMP initiates meiotic maturation in mouse oocytes.
  • Cyclic AMP-dependent protein kinase (PK) mediates meiotic arrest, and its inhibition triggers maturation.
  • Specific changes in oocyte phosphoproteins are linked to meiotic resumption and are regulated by the cAMP/PK pathway.

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Meiosis II02:02

Meiosis II

Meiosis II entails cell division and segregation of the sister chromatids, resulting in the production of four unique haploid gametes. The steps for meiosis II are similar to mitosis, except that meiosis II occurs in haploid cells, whereas mitosis occurs in diploid cells.
The timing and cell division patterns of meiosis differ between males and females. In male meiosis, the centrosomes are part of the formation of the meiotic spindle. However, in oocytes, including that of humans, Drosophila,...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...